These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29547938)

  • 1. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
    He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
    Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opa interacting protein 5 acts as an oncogene in bladder cancer.
    He X; Hou J; Ping J; Wen D; He J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
    Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
    Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
    Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
    Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling.
    Peng JM; Tseng RH; Shih TC; Hsieh SY
    Cancer Lett; 2021 Jan; 497():66-76. PubMed ID: 33068700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
    Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
    Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
    Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D
    Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
    Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
    Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
    Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
    Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
    Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.
    Rodrigues-Junior DM; Biassi TP; Carlin V; Buri MV; Torrecilhas AC; Bortoluci KR; Vettore AL
    J Mol Neurosci; 2018 Nov; 66(3):383-389. PubMed ID: 30284228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer.
    Ren X; Chen C; Luo Y; Liu M; Li Y; Zheng S; Ye H; Fu Z; Li M; Li Z; Chen R
    Mol Cancer; 2020 Feb; 19(1):35. PubMed ID: 32085715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
    Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
    Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition.
    Blum R; Nakdimon I; Goldberg L; Elkon R; Shamir R; Rechavi G; Kloog Y
    Int J Cancer; 2006 Aug; 119(3):527-38. PubMed ID: 16496386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.
    Yin J; Fu W; Dai L; Jiang Z; Liao H; Chen W; Pan L; Zhao J
    Sci Rep; 2017 Jun; 7(1):4430. PubMed ID: 28667340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.